Cem Ozenc is corporate vice president and Oceania general manager for Novo Nordisk, the Danish pharmaceuticals company behind the obesity drugs Ozempic and Wegovy. He lives in Sydney.
How did you get into climbing and how old were you?
In my late 20s, I was already into individual endurance sports like running, cycling and triathlons, so mountaineering seemed like a natural next step. It offered a unique way to challenge myself physically and mentally. Climbing also provided a great opportunity for self‑reflection and personal growth.